The alliance of sphingosine-1-phosphate and its receptors in immunity
Open accessThe DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Abstract
Sphingosine-1-phosphate (S1P) is a biologically active metabolite of plasma-membrane sphingolipids that is essential for immune-cell trafficking. Its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity. Much of the immune function of S1P results from the engagement of a family of G-protein-coupled receptors (S1PR1-S1PR5). Recent findings on the role of S1P in immunosurveillance, the discovery of regulatory mechanisms in S1P-mediated immune-cell trafficking and new advances in understanding the mechanism by which S1P affects immune-cell function indicate that the alliance between S1P and its receptors has a fundamental role in immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The multiple biological activities of S1P are mediated by five distinct G protein-coupled receptors (S1PR1–5), which are differently expressed in various tissues163.”
From Atopic dermatitis: an expanding therapeutic pipeline for a complex disease (2022) · cites this paper as [163]
In the citing paper
“Sphingosine receptors play an important role in innate immune responses (120), and sphingosine analogs have shown potential for controlling the cytokine storm caused by influenza virus (95).”
From Into the Eye of the Cytokine Storm (2012) · cites this paper as [120]
Citations
Cites
1 retracted
Melendez, A. J., & Khaw, A. K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110944200 · Cited by 159
RetractedPrinciples of bioactive lipid signalling: lessons from sphingolipids
Hannun, Y. A., & Obeid, L. M. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2329 · Cited by 3,333 · cited 1×
“Two sphingosine kinases ( SPHK1 and SPHK2 ) then phosphorylate sphingosine to generate the lysosphingolipid sphingosine-1-phosphate (S1P”
BackgroundLymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1
Matloubian, M., Lo, C. G., Cinamon, G., Lesneski, M. J., Xu, Y., Brinkmann, V., Allende, M. L., Proia, R. L., & Cyster, J. G. (2004) · Nature · doi:10.1038/nature02284 · Cited by 2,581
Self-citationThe Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors
Brinkmann, V., Davis, M. D., Heise, C. E., Albert, R., Cottens, S., Hof, R., Bruns, C., Prieschl, E., Baumruker, T., Hiestand, P., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200176200 · Cited by 1,504 · cited 1×
“A breakthrough in the understanding of its mechanism, together with a link to S1PR signalling, came with the realization that FTY720 is a sphingosine analogue that could be phosphorylated by SPHKs to produce a S1PR ligan”
BackgroundCD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
Shiow, L. R., Rosen, D. B., Brdičková, N., Xu, Y., An, J., Lanier, L. L., Cyster, J. G., & Matloubian, M. (2006) · Nature · doi:10.1038/nature04606 · Cited by 1,189
Liu, Y., Wada, R., Yamashita, T., Mi, Y., Deng, C.-X., Hobson, J. P., Rosenfeldt, H. M., Nava, V. E., Chae, S.-S., Lee, M.-J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10905 · Cited by 1,149 · cited 1×
“Further support is provided by the well-documented role of S1PR1 in regulating endothelial-cell organization during developmen”
BackgroundSelf-citationOral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
Kappos, L., Antel, J., Comi, G., Montalban, X., O'Connor, P., Polman, C. H., Haas, T., Korn, A. A., Karlsson, G., & Radue, E. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052643 · Cited by 1,054 · cited 1×
“By contrast, treatment of patients with relapsing–remitting multiple sclerosis with considerably lower doses of FTY720 alone has proven to be beneficia”
ResultPromotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate
Pappu, R., Schwab, S. R., Cornelissen, I., Pereira, J. P., Regard, J. B., Xu, Y., Camerer, E., Zheng, Y.-W., Huang, Y., Cyster, J. G., et al. (2007) · Science · doi:10.1126/science.1139221 · Cited by 877
Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients
Schwab, S. R., Pereira, J. P., Matloubian, M., Xu, Y., Huang, Y., & Cyster, J. G. (2005) · Science · doi:10.1126/science.1113640 · Cited by 787 · cited 1×
“Notable exceptions are the blood, where S1P levels are in the low-micromolar range and are mainly contributed by erythrocytes, and the lymph, where S1P levels are in the hundred-nanomolar rang”
BackgroundEssential Role for Sphingosine Kinases in Neural and Vascular Development
Mizugishi, K., Yamashita, T., Olivera, A., Miller, G. F., Spiegel, S., & Proia, R. L. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.24.11113-11121.2005 · Cited by 742 · cited 1×
“More specifically, deletion of the genes that encode both kinases is embryonic lethal and results in embryos lacking S1”
BackgroundSelf-citation
Cited by
Items 301–400 of 634
Microglia‐leucocyte axis in cerebral ischaemia and inflammation in the developing brain
Rayasam, A., Fukuzaki, Y., & Vexler, Z. S. (2021) · Acta Physiologica · doi:10.1111/apha.13674 · Cited by 33
Jung, Y., Lopez-Benitez, J., Tognoni, C. M., Carreras, I., & Dedeoglu, A. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148171 · Cited by 35
Review: Innate immunity, lipid metabolism and nutrition in canine atopic dermatitis
Pucheu‐Haston, C. M., Santoro, D., Bizikova, P., Eisenschenk, M. N. C., Marsella, R., & Nuttall, T. J. (2015) · Veterinary Dermatology · doi:10.1111/vde.12199 · Cited by 29
Bae, S. J., Lee, S. H., Ahn, S. H., Kim, H.-M., Kim, B., & Koh, J. (2016) · Osteoporosis International · doi:10.1007/s00198-016-3565-z · Cited by 33
Black, L. L., Srivastava, R., Schoeb, T. R., Moore, R. D., Barnes, S., & Kabarowski, J. H. S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500806 · Cited by 31
“1-phosphate, also warrant investigation with respect to mechanisms of ApoA-I–mediated immune suppression and antiinflammatory action in SLE (2, 64, 65).”
BackgroundDon‐Doncow, N., Zhang, Y., Matušková, H., & Meißner, A. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14381 · Cited by 31
“A major determinant for T-cell mobilization is the existing S1P gradient between tissue and blood that drives lymphocyte egress and homing (Rivera et al., 2008) and is governed by S1P1 receptor surface expression on T-cells (Matloubian et al., 2004).”
BackgroundInfluentialLange, M. D., Abernathy, J. W., & Farmer, B. D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01175 · Cited by 33
Karuppuchamy, T., Tyler, C. J., Lundborg, L. R., Pérez-Jeldres, T., Kimball, A. K., Clambey, E. T., Jedlicka, P., & Rivera–Nieves, J. (2019) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz174 · Cited by 30
Role of T cells in ischemic acute kidney injury and repair
Lee, K., & Jang, H. R. (2022) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2021.526 · Cited by 28
“Sphingosine-1-phosphate (S1P) and S1P receptor (S1PR) signaling is required for T cell trafficking to peripheral tissues from lymphoid organs, and S1PR1 selective agonists block T cell egress from lymphoid tissue [46].”
BackgroundTatsumi, N., Codrington, A. L., El-Fenej, J., Phondge, V., & Kumamoto, Y. (2021) · Science Immunology · doi:10.1126/sciimmunol.abg0336 · Cited by 30
Olivera, A., Dillahunt, S., & Rivera, J. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.01.005 · Cited by 28
Self-citationLester, R. L., Withers, B. R., Schultz, M. A., & Dickson, R. C. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2012.12.012 · Cited by 34
Angst, D., Janser, P., Quancard, J., Buehlmayer, P., Berst, F., Oberer, L., Beerli, C., Streiff, M. B., Pally, C., Hersperger, R., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3009508 · Cited by 28
Rapid Histamine-Induced Neutrophil Recruitment Is Sphingosine Kinase-1 Dependent
Sun, W. Y., Abeynaike, L., Escarbe, S., Smith, C. D., Pitson, S. M., Hickey, M. J., & Bonder, C. S. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.12.024 · Cited by 32
Resop, R. S., Douaisi, M. P., Craft, J. F., Jachimowski, L. C. M., Blom, B., & Uíttenbogaart, C. H. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.12.1339 · Cited by 32
Novel Structural Approaches to Study GPCR Regulation
Alfonzo‐Méndez, M. A., Alcántara-Hernández, R., & García-Sáinz, J. A. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010027 · Cited by 30
“Down-regulation of S1P1 receptor seems to play a key role in lymphocyte migration [71] and astrocyte activation [72].”
BackgroundSphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015)
Guerrero, M. A., Urbano, M., & Roberts, E. (2016) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2016.1157165 · Cited by 33
Kleinwort, A., Lührs, F., Heidecke, C.-D., Lipp, M., & Schulze, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020391 · Cited by 28
“The crucial regulatory role of S1P has been shown in the immune system (reviewed in [5,6]),”
BackgroundSchumacher, F., Neuber, C., Finke, H., Nieschalke, K., Baesler, J., Gulbins, E., & Kleuser, B. (2017) · Journal of Lipid Research · doi:10.1194/jlr.m076562 · Cited by 27
“For example, binding of S1P to the S1P1 receptor is a key event regulating both the homing of immune cells to lymphoid organs and their release into blood and lymph fluid (4).”
BackgroundThe role of cytokine and immune responses in intestinal fibrosis
Yang, B., Zhang, G., Elias, M. G., Zhu, Y., & Wang, J. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12879 · Cited by 28
“The S1P gradient between the tissues and vascular compartments determines the egress and homing of immune cells.(82) Recently, S1P has become a target in the treatment of IBD.”
BackgroundFunction and therapeutic value of astrocytes in diabetic cognitive impairment
Meng, F., Fu, J., Zhang, L., Guo, M., Zhuang, P., Yin, Q., & Zhang, Y. (2023) · Neurochemistry International · doi:10.1016/j.neuint.2023.105591 · Cited by 31
Potì, F., Bot, M., Costa, S., Bergonzini, V., Maines, L. W., Varga, G., Freise, H., Robenek, H., Simoni, M., & Nofer, J. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-08-0583 · Cited by 27
“Numerous studies revealed regulatory influence of S1P on lymphocyte distribution and T cell function (8, 9).”
BackgroundYu, H. H., Sun, C., & Argraves, K. M. (2015) · Journal of Periodontal Research · doi:10.1111/jre.12276 · Cited by 30
“In contrast, S1P levels in blood are very high (low μM range) because erythrocytes and platelets produce abundant S1P (9, 10).”
BackgroundNovel therapies for the treatment of pertussis disease
Scanlon, K. M., Skerry, C. M., & Carbonetti, N. H. (2015) · Pathogens and Disease · doi:10.1093/femspd/ftv074 · Cited by 29
Pleiotropic Roles of Type 1 Interferons in Antiviral Immune Responses
Teijaro, J. R. (2016) · Advances in immunology · doi:10.1016/bs.ai.2016.08.001 · Cited by 29
“Signaling through these five receptors is known to modulate multiple cellular processes including: cell adhesion, migration, survival, proliferation, endocytosis, barrier function, and cytokine production (Rivera, Proia, & Olivera, 2008) .”
BackgroundAbhyankar, V., Kaduskar, B., Kamat, S. S., Deobagkar, D. D., & Ratnaparkhi, G. S. (2018) · Journal of Experimental Biology · doi:10.1242/jeb.187989 · Cited by 35
“We found that levels of several other lipid classes including neutral lipids, phospholipids (except PE), sphingomyelins and sterols remained unchanged, indicating a specific role for Mt2 in the regulation of sphingolipid metabolism (Acharya and Acharya, 2005; Kraut, 2011; Saba and Hla, 2004), especially those importan…”
BackgroundFarkas, B., Boldizsár, F., Tarjányi, O., László, A., Lin, S. M., Hutás, G., Tryniszewska, B., Mangold, A. R., Nagyéri, G., Rosenzweig, H. L., et al. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2613 · Cited by 28
“Twentythree genes showed greater than twofold differences (Figure 2), and 11 of the 77 genes were described as immune response genes or associated with arthritis (Additional data file 1) [30-65].”
BackgroundSphingosine-1-phosphate induces airway smooth muscle hyperresponsiveness and proliferation
Maguire, T. J. A., Yung, S., Zapater, E. O., Kayode, O. S., Till, S. J., Corrigan, C. J., Siew, L. Q. C., Knock, G. A., & Woszczek, G. (2023) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2023.05.028 · Cited by 25
Xie, S., Zhang, H., Xie, Z., Liu, Y., Gao, K., Zhang, J., Xie, S., Wang, F., Fan, R., & Jiang, W. (2021) · Disease Markers · doi:10.1155/2021/5558458 · Cited by 25
“Sphingolipids are ubiquitous components of the cell membrane and play an important role in cell growth, inflammation, and tissue remodeling [27, 28].”
BackgroundMuse cells: ushering in a new era of stem cell-based therapy for stroke
Li, H., Wei, J., Liu, X., Zhang, P., & Lin, J. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-022-03126-1 · Cited by 26
“SIP is a signal for acute inflammation/ damage and is produced by damaged cells [73].”
BackgroundNeuroinflammation: Molecular Mechanisms And Therapeutic Perspectives
Meccariello, R., Marino, M., Mele, E., Pastorino, G. M. G., Operto, F. F., Santoro, A., & Viggiano, A. (2022) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524922666220929153215 · Cited by 30
Sphingosine‐1‐phosphate controls endothelial sphingolipid homeostasis via ORMDL
Sasset, L., Chowdhury, K. H., Manzo, O. L., Rubinelli, L., Konràd, C., Maschek, J. A., Manfredi, G., Holland, W. L., & Lorenzo, A. D. (2022) · EMBO Reports · doi:10.15252/embr.202254689 · Cited by 27
“Within the cardiovascular and immune systems, S1P is necessary for vascular development (Liu et al , 2000) and homeostasis (Yanagida & Hla, 2017) as well as immune cell trafficking (Rivera et al , 2008), mainly via S1PR1.”
Paepe, E. D., Plekhova, V., Vangeenderhuysen, P., Baeck, N., Bullens, D. M. A., Claeys, T., Graeve, M. D., Kamoen, K., Notebaert, A., de Wiele, T. V., et al. (2024) · Allergy · doi:10.1111/all.16005 · Cited by 26
“53 The presence of inflammatory conditions was further corroborated by decreased levels of the antioxidant metabolites 4-hydroxybenzaldehyde 39 and 2-oxindole.”
BackgroundGatfield, J., Monnier, L., Studer, R. O., Bolli, M. H., Steiner, B., & Nayler, O. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.03.029 · Cited by 26
Diesner, S. C., Olivera, A., Dillahunt, S., Schultz, C., Watzlawek, T., Förster‐Waldl, E., Pollak, A. J., Jensen‐Jarolim, E., Untersmayr, E., & Rivera, J. (2011) · Immunology Letters · doi:10.1016/j.imlet.2011.10.006 · Cited by 27
“The expression of S1PR1 on mast cells as well as on other immune cells is crucial for migration.[16] Jolly et al.”
BackgroundSelf-citationMicro RNA ‐mediated regulation of immune responses to intestinal helminth infections
Entwistle, L. J., & Wilson, M. S. (2016) · Parasite Immunology · doi:10.1111/pim.12406 · Cited by 26
Don‐Doncow, N., Vanherle, L., Zhang, Y., & Meißner, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030537 · Cited by 30
“Furthermore, S1P gradients between tissues critically drive lymphocyte egress and homing [6,33,47].”
Zheng, H., Yu, J., Gao, L., Wang, K., Xu, Z., Zeng, Z., Zheng, K., Tang, X., Tian, X., Zhao, Q., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57124-x · Cited by 33
Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines
Bolli, M. H., Abele, S., Birker, M., Bravo, R., Bur, D., de Kanter, R., Kohl, C., Grimont, J., Hess, P., Lescop, C., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm4014696 · Cited by 28
Regulation of Immune Cell Migration by Sphingosine-1-Phosphate
Kumar, A. (2015) · Cellular and Molecular Biology · doi:10.5281/zenodo.10608867 · Cited by 25
Romani, R., Manni, G., Donati, C., Pirisinu, I., Bernacchioni, C., Gargaro, M., Pirro, M., Calvitti, M., Bagaglia, F., Sahebkar, A., et al. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.06.005 · Cited by 28
“, 2005; Spiegel and Milstien, 2002) – recent evidence suggests that S1P is also an important mediator of both innate and adaptive immune responses (Rivera et al., 2008).”
BackgroundPrice, M. M., Kapitonov, D., Allegood, J. C., Milstien, S., Oskeritzian, C. A., & Spiegel, S. (2009) · The FASEB Journal · doi:10.1096/fj.08-128900 · Cited by 25
Discovery of CS-2100, a potent, orally active and S1P3-sparing S1P1 agonist
Nakamura, T., Asano, M., Sekiguchi, Y., Mizuno, Y., Tamaki, K., Kimura, T., Nara, F., Kawase, Y., Shimozato, T., Doi, H., et al. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.019 · Cited by 24
Khattar, M., Deng, R., Kahan, B. D., Schroder, P. M., Phan, T., Rutzky, L. P., & Stepkowski, S. M. (2013) · Transplantation · doi:10.1097/tp.0b013e3182842396 · Cited by 24
“Over the last 10 years, a new class of analogues for sphingosine1-phosphate (S1P) has emerged as potential therapeutic modulators of immunity (4).”
BackgroundLipid-Modifying Enzymes in Human Tear Fluid and Corneal Epithelial Stress Response
Robciuc, A., Rantamäki, A. H., Jauhiainen, M., & Holopainen, J. M. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.13-12577 · Cited by 25
Fazekas, F., Bajenaru, O. A., Berger, T., Fabjan, T. H., Ledinek, A. H., Jakab, G., Komoly, S., Kobys, T. O., Kraus, J., Kurča, E., et al. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00010 · Cited by 23
“S1P has important functions in the immune system, CNS and cardiovascular system, and S1P signaling plays a key role in neuroinflammatory processes (Spiegel and Milstien, 2003; Brinkmann, 2007, 2009; Rivera et al., 2008; Aktas et al., 2010).”
BackgroundIshimaru, N., Yamada, A., Nitta, T., Arakaki, R., Lipp, M., Takahama, Y., & Hayashi, Y. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.09.027 · Cited by 24
Tsai, H., Huang, Y., Garris, C., Moreno, M. A., Griffin, C., & Han, M. H. (2016) · JCI Insight · doi:10.1172/jci.insight.86462 · Cited by 25
“Studies by others have also shown that S1P signaling modulates macrophage and dendritic cell functions (18).”
BackgroundS1P Provokes Tumor Lymphangiogenesis via Macrophage-Derived Mediators Such as IL-1βor Lipocalin-2
Syed, S. N., Jung, M., Weigert, A., & Brüne, B. (2017) · Mediators of Inflammation · doi:10.1155/2017/7510496 · Cited by 25
“Expectedly, enhanced S1P production has been implicated in various physiological and pathological processes including cancer and autoimmune inflammation [27, 28].”
Luo, Z., Rosenberg, A. J., Liu, H., Han, J., & Tu, Z. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.03.035 · Cited by 24
“It was reported that S1P/S1PR1 signaling system plays a key role in immune-mediated diseases, such as multiple sclerosis (MS) [2, 3], colitis [4], influenza [5], rheumatoid arthritis [6], inflammatory bowel disease [7], and atherosclerosis [8, 9].”
BackgroundLipocalin 2: A New Antimicrobial in Mast Cells
Chang, Y.-L., Wang, Z., Igawa, S., Choi, J. E., Werbel, T., & Nardo, A. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102380 · Cited by 24
“S1P in the immune cell is essential for cell trafficking and its concentration is increased in many inflammatory conditions, such as asthma and autoimmunity [26].”
BackgroundZwierzchowski, G., Zhang, G., Mandal, R., Wishart, D. S., & Ametaj, B. N. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b08312 · Cited by 25
Yu, H. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094411 · Cited by 26
“S1P is derived from sphingosine when sphingosine kinase (SphK) 1 and/or SphK2 are activated by various stimuli, including growth factors, hormones, bacterial stimuli, and cytokines (Figure 1) [16,20,21].”
BackgroundPaik, J. H., Nam, S. J., Kim, T. M., Heo, D. S., Kim, C. W., & Jeon, Y. K. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-911 · Cited by 26
“S1P is produced intracellularly by sphingosine kinase (SPHK) 1/2; it is released from the cells and then binds to the S1P receptors (S1PR1-S1PR5) of target cells in an autocrine and/or paracrine manner [20,21].”
BackgroundArish, M., Alaidarous, M., Ali, R. A., Akhter, Y., & Rub, A. (2017) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2017.1358282 · Cited by 24
“There are five specific cell surface G-protein-coupled receptors for S1P, termed as S1PR1–5 [53].”
BackgroundZhao, Y., Shi, D., Cao, K., Wu, F., Zhu, X., Wen, S., You, Q., Zhang, K., Liu, L., & Zhou, H. (2017) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0717-287r · Cited by 25
Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia
Hsu, S.-C., Chang, J.-H., Hsu, Y.-P., Bai, K.-J., Huang, S.-K., & Hsu, C.-W. (2019) · PLOS ONE · doi:10.1371/journal.pone.0216963 · Cited by 23
Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells
Bendall, L. J., & Basnett, J. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283606090 · Cited by 22
“As S1P regulates cell trafficking through surface receptors [11], the role of S1P in signaling events will not be discussed here.”
BackgroundWu, H., Yang, C., Hao, R., Liao, Y., Wang, Q., & Deng, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1018423 · Cited by 29
“Moreover, the anti-inflammatory effects of sphingosine have also been described, which are related to the transformation of pro-inflammatory M1 subtype macrophage (39).”
BackgroundEmerging roles of host and microbial bioactive lipids in inflammatory bowel diseases
Kayama, H., & Takeda, K. (2023) · European Journal of Immunology · doi:10.1002/eji.202249866 · Cited by 22
Perspectives on immunomodulation early in life
Diesner, S. C., Förster‐Waldl, E., Olivera, A., Pollak, A. J., Jensen‐Jarolim, E., & Untersmayr, E. (2012) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.2011.01259.x · Cited by 26
“In particular, the metabolites of the sphingolipid catabolism, sphingosine and sphingosine-1 phosphate (S1P), and the enzymes involved in their synthesis and degradation [sphingosine kinase (SphK) and S1P lyase], directly affect cell motility, calcium homeostasis, cell survival and differentiation and modulate immune-…”
BackgroundSelf-citationAnalysis of sphingosine kinase activity in single natural killer cells from peripheral blood
Dickinson, A. J., Meyer, M., Pawlak, E. A., Gomez, S. M., Jaspers, I., & Allbritton, N. L. (2015) · Integrative Biology · doi:10.1039/c5ib00007f · Cited by 27
Borge, M., Lenicov, F. R., Nannini, P. R., Alicandú, M. M. D. L. R., Podaza, E., Ceballos, A., Grecco, H. F., Cabrejo, M., Bezares, R. F., Morande, P. E., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400547 · Cited by 28
“organs, favoring lymphocyte egress (5).”
Sphingolipid Metabolism of a Sea Anemone Is Altered by the Presence of Dinoflagellate Symbionts
Kitchen, S. A., Poole, A. Z., & Weis, V. M. (2017) · Biological Bulletin · doi:10.1086/695846 · Cited by 25
Lai, A. Y., Watanabe, A., O’Brien, T., & Kondo, M. (2009) · Blood · doi:10.1182/blood-2009-01-201939 · Cited by 25
Zhou, X., Liu, X., Yang, X., Wang, L., Hong, Y., Lian, K., Qiu, G., Shang, X., Ma, Z., Yuan, H., et al. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120958 · Cited by 22
Qiu, L., Jiang, H., Yu, Y., Gu, J., Wang, J., Zhao, H., Huang, T., Gropler, R. J., Klein, R. S., Perlmutter, J. S., et al. (2021) · Organic & Biomolecular Chemistry · doi:10.1039/d1ob02225c · Cited by 21
The Crosstalk between FcεRI and Sphingosine Signaling in Allergic Inflammation
Jo, H., Shim, K., & Jeoung, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232213892 · Cited by 22
“Sphingolipids are present in the cell membrane and provide structural integrity; they can mediate cell signaling, cell survival and differentiation, immune cell trafficking, and vascular and mucosal integrities [1,2].”
BackgroundXu, M., Liu, D., Ding, L., Ma, K., Wu, M., Lv, L., Wen, Y., Liu, H., Tang, R., & Liu, B. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.100 · Cited by 21
Immune Regulation by Sphingosine 1-Phosphate and Its Receptors
Bode, C., & Gräler, M. H. (2011) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-011-0159-5 · Cited by 20
Bruno, M., Rizzo, I. M., Romero‐Guevara, R., Bernacchioni, C., Cencetti, F., Donati, C., & Bruni, P. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.02.004 · Cited by 24
Martínez-Morales, J. C., Romero‐Ávila, M. T., Reyes‐Cruz, G., & García-Sáinz, J. A. (2018) · Bioscience Reports · doi:10.1042/bsr20181612 · Cited by 25
Drugging cancer metabolism: Expectations vs. reality
Montrose, D. C., & Galluzzi, L. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.07.007 · Cited by 24
Metabolite profiles associated with disease progression in influenza infection
Wendt, C. H., Castro‐Pearson, S., Proper, J. L., Pett, S. L., Griffin, T. J., Kan, V. L., Carbone, J., Koulouris, N. G., Reilly, C., Neaton, J. D., et al. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247493 · Cited by 21
“Sphingolipid metabolites play key roles in immune cell migration and function [16, 17] and have been associated with sepsis and poor outcomes [18].”
BackgroundPennington, L. D., Sham, K. K. C., Pickrell, A. J., Harrington, P. E., Frohn, M. J., Lanman, B. A., Reed, A. B., Croghan, M. D., Lee, M. R., Xu, H., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml2001399 · Cited by 20
Nema, R., & Kumar, A. (2021) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2021.697922 · Cited by 21
“Infiltration of Immune Cells in BC Expression of S1P receptor(s) on immune cells is essential for their transport among various tissues, including lymph nodes, bone marrow, and tumor tissues (Rivera et al., 2008).”
BackgroundIntracellular Sphingosine-1-Phosphate Receptor 3 Contributes to Lung Tumor Cell Proliferation
Terlizzi, M., Colarusso, C., Ferraro, G., Monti, M. C., Rosa, I. D., Somma, P., Salvi, R., Pinto, A., & Sorrentino, R. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000431 · Cited by 20
Zhang, Z., Li, Y., Shi, J., Zhu, L., Dai, Y., Fu, P., Liu, S., Hong, M., Zhang, J., Wang, J., et al. (2022) · Aging and Disease · doi:10.14336/ad.2022.1102 · Cited by 21
“As a potential target, sphingosine 1phosphate (S1P) has shown the ability to regulate the trafficking of immune cells from peripheral blood to the injured brain through the G-protein-coupled S1P receptor (S1PR) after stroke [27, 28].”
BackgroundMori, H., Izawa, T., & Tanaka, E. I. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.06.015 · Cited by 21
“The S1P receptor is expressed on the cell surface and is internalized on binding of an S1P ligand as part of the migratory response.(30) To analyze the expression of the S1P”
BackgroundTerashita, T., Kobayashi, K., Nagano, T., Kawa, Y., Tamura, D., Nakata, K., Yamamoto, M., TACHIHARA, M. Y., Kamiryo, H., & Nishimura, Y. (2016) · Respiratory Research · doi:10.1186/s12931-016-0465-x · Cited by 20
“Sphingosine-1-phosphate (S1P) is a bioactive phospholipid metabolite [1].”
BackgroundImmune Responses of Chickens Infected with Wild Bird-Origin H5N6 Avian Influenza Virus
Gao, S., Kang, Y., Yuan, R., Ma, H., Xiang, B., Wang, Z., Dai, X., Wang, F., Xiao, J., Liao, M., et al. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.01081 · Cited by 22
“As an indispensable regulator of inflammation activation, S1PR1 plays a crucial role in immune cell trafficking and immune response (Rivera et al., 2008).”
BackgroundIn Situ Patrolling of Regulatory T Cells Is Essential for Protecting Autoimmune Exocrinopathy
Ishimaru, N., Nitta, T., Arakaki, R., Yamada, A., Lipp, M., Takahama, Y., & Hayashi, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008588 · Cited by 23
“Although recent work has shown that S1P is required for induction of egress [31,32], the mechanism by which S1P1 acts to regulate the traffic of Treg cells has been unclear.”
BackgroundHsu, C., Suk, C., Hsu, Y.-P., Chang, J., Liu, C.-T., Huang, S., & Hsu, S. (2022) · Respiratory Research · doi:10.1186/s12931-022-01991-1 · Cited by 23
Wang, S., Tian, Z., Lu, Y., Huang, Z., Fan, Y., Li, B., Zheng, H., Wu, X., Wang, M., Zhao, J., et al. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.80256 · Cited by 19
“Among the S1PRs confirmed of binding to different G protein’s subunits [16], S1PR1-3 are well-characterized in the processes of various diseases, whereas the function of S1PR4 has been underappreciated [17-19].”
BackgroundAttenuation of murine sclerodermatous models by the selective S1P1 receptor modulator cenerimod
Kano, M., Kobayashi, T., Date, M., Tennichi, M., Hamaguchi, Y., Strasser, D. S., Takehara, K., & Matsushita, T. (2019) · Scientific Reports · doi:10.1038/s41598-018-37074-9 · Cited by 22
Masuko, K., Murata, M., Beppu, M., Nakamura, H., Kato, T., & Yudoh, K. (2012) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2012.01756.x · Cited by 23
Guerrero, M. A., Urbano, M., Zhao, J., Crisp, M., Chase, P. S., Hodder, P., Schaeffer, M., Brown, S. J., Rosen, H., & Roberts, E. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.096 · Cited by 19
Gutbier, B., Schönrock, S. M., Ehrler, C., Haberberger, R. V., Dietert, K., Gruber, A. D., Kummer, W., Michalick, L., Kuebler, W. M., Hocke, A. C., et al. (2018) · Critical Care Medicine · doi:10.1097/ccm.0000000000002916 · Cited by 19
Juif, P., Baldoni, D., Reyes, M., Wilbraham, D., Febbraro, S., Vaclavkova, A., Hoch, M., & Dingemanse, J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122636 · Cited by 18
Discovery, design and synthesis of a selective S1P3 receptor allosteric agonist
Guerrero, M. A., Poddutoori, R., Urbano, M., Peng, X., Spicer, T., Chase, P. S., Hodder, P., Schaeffer, M., Brown, S. J., Rosen, H., et al. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.09.075 · Cited by 18
Li, K., Fähnrich, A., Roy, E., Cuda, C. M., Grimes, H. L., Perlman, H., Kalies, K., & Hildeman, D. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601200 · Cited by 20
“1C, 1D), suggesting their postselection state (49).”
Mast cells and sphingosine‐1‐phosphate underlie prelesional remodeling in a mouse model of eczema
Wedman, P., Al-Adhami, A., Chumanevich, A. P., Fuseler, J. W., & Oskeritzian, C. A. (2017) · Allergy · doi:10.1111/all.13310 · Cited by 20
“MC can be activated by S1P, an influential sphingolipid metabolite resulting from the phosphorylation of its precursor sphingosine by SphK.(20,21,25,27,44) Quantitative lipid analysis using lipidomics mass spectrometry(33) revealed that S1P was significantly increased in mouse skin after 1 exposure to OVA, compared to…”
BackgroundZuo, L., Zhou, L., Xu, T., Li, Z., Liu, L., Shi, Y., Kang, J., Gao, G., Du, S., Sun, Z., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00300 · Cited by 17
“S1P had been proved a good anti-inflammatory effects and this anti-inflammatory mechanism might be weaken in sepsis with low S1P level (Rivera et al., 2008).”
BackgroundTamehiro, N., Mujawar, Z., Zhou, S., Zhuang, D. Z., Hornemann, T., von Eckardstein, A., & Fitzgerald, M. L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014365 · Cited by 18
Pennington, L. D., Croghan, M. D., Sham, K. K. C., Pickrell, A. J., Harrington, P. E., Frohn, M. J., Lanman, B. A., Reed, A. B., Lee, M. R., Xu, H., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.10.085 · Cited by 18
Vasconcelos, J. F., Meira, C. S., Silva, D. N., Nonaka, C. K. V., Daltro, P. S., Macambira, S. G., Domizi, P., Borges, V. M., Ribeiro‐dos‐Santos, R., Souza, B. S. D. F., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06275-z · Cited by 20
Liu, J., Zhang, L., Liu, L., Wu, T., Wang, L., & Han, Q. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117508 · Cited by 19
Synthesis and evaluation of CS-2100, a potent, orally active and S1P3- sparing S1P1 agonist
Nakamura, T., Asano, M., Sekiguchi, Y., Mizuno, Y., Tamaki, K., Nara, F., Kawase, Y., Yabe, Y., Nakai, D., Kamiyama, E., et al. (2012) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2012.02.022 · Cited by 17
Tong, S., Tian, J., Wang, H., Huang, Z., Yu, M., Sun, L., Liu, R., Liao, M., & Ning, Z. (2013) · Virology Journal · doi:10.1186/1743-422x-10-296 · Cited by 19
“The S1PR1 signaling system exerts its influence on a wide range of physiologic processes via activation of several signaling pathways: JAK/STAT, mTOR/ PI3K/Akt, Ras/ERK/MAPK, Phospholipase C activation of PKC/Ca and cyclic AMP [14,15].”
BackgroundMast cell function in physiology and pathophysiology
Gerhard, J. (2010) · Cited by 17
Metadata
- Authors
- Rivera, J., Proia, R. L., & Olivera, A.
- Affiliations
- National Institutes of Health (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
- Corresponding author
- Rivera, Juan
- Venue
- Nature Reviews Immunology
- Published
- 2008-10
- Volume
- 8
- Issue
- 10
- Pages
- 753-763
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2600775
- OpenAlex
- W1967802627
- Cited by
- 616
- References
- 108
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 18 · 2023: 30 · 2022: 26 · 2021: 38 · 2020: 30 · 2019: 40 · 2018: 37 · 2017: 34 · 2016: 41 · 2015: 36 · 2014: 46 · 2013: 46 · 2012: 58
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (Z01AR041155)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Keywords
- sphingosine-1-phosphate, S1P receptors, G protein-coupled receptors, immune cell trafficking, immunomodulation, immune surveillance, immune cell function, inflammation, asthma, autoimmunity, sphingolipids
- MeSH terms
- Animals, Cell Movement, Chemotaxis, Dendritic Cells, Humans, Lymphocytes, Lysophospholipids, Macrophages, Mast Cells, Sphingosine, Signal Transduction, Receptors, Lysosphingolipid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.